An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
Inspired by the Grands Ecoles model in France, in particular the Ecole des Hautes Etudes Commerciales in Paris (HEC Paris), HEC Montréal was founded in 1907 by the Board of Trade of Metropolitan ...
As per the latest notification, the commission will fill 1,096 vacancies through RPSC RAS 2024 instead of 733. The official notification and post-wise distribution of vacancies are available at ...
In one of the most far-reaching changes to Pakistan's higher education admission system in recent years, Higher Education Commission Pakistan has centralised the MPhil and PhD admission process by ...
The Higher Education Commission of Pakistan (HEC) on Monday announced the launch of a “fully online and paperless” degree attestation system to facilitate students. In December last year, the HEC said ...
AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...
ZyDoc unveils no-cost clinical documentation with a 7-day human-edited trial at HIMSS NY, delivering secure, onshore solutions with proven ROI for providers. NEW YORK ...
NEW YORK, NY, UNITED STATES, April 8, 2026 /EINPresswire.com/ — ZyDoc, a leader in clinical documentation solutions, announced its sponsorship of the HIMSS New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results